Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
VivoPower Announces Pricing of $25.0 Million Underwritten Public Offering of Ordinary Shares
-
First Republic Bank (FRC) PT Raised to $150 at Maxim Group, Following Earnings
-
Maxim Lighting and ET2 Contemporary Lighting present our 2020 New Releases
-
Maxim Lighting and ET2 Contemporary Lighting present our 2020 New Releases
-
Gladstone Land Corporation Announces Pricing of Common Stock Offering
-
The9 Announces Closing of US$8.7 Million Underwritten Offering
-
Mesoblast Limited (MSB:AU) (MESO) PT Lowered to $18 at Maxim Group, After Receiving FDA Complete Response Letter
-
Maxim Group Downgrades Synthetic Biologics (SYN) to Hold, Following Clinical Trial Update
-
Maxim Group Starts Summit Wireless (WISA) at Buy
-
Siyata Mobile Announces Closing of its Upsized US$12.6 Million U.S. Initial Public Offering on the NASDAQ
-
Siyata Mobile Announces Closing of its Upsized US$12.6 Million U.S. Initial Public Offering on the NASDAQ
-
The9 Limited (NCTY) Prices 23.5M ADS Common Offering at $0.37/ADS
-
The9 Announces Pricing of US$8.7 Million Underwritten Offering
-
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
-
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
-
Orgenesis (ORGS) Reports Acquisition of Koligo Therapeutics
-
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
-
Maxim Group Upgrades Inovio Pharmaceuticals (INO) to Buy, Following Business Update
-
BioMedNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Equity Research Company Update
-
Manhattan Harbor Capital Continues Impressive Expansion in the United States with the Launch of Kingswood Capital Markets
-
Manhattan Harbor Capital Continues Impressive Expansion in the United States with the Launch of Kingswood Capital Markets
-
Globus Maritime Limited Reports Financial Results for the Quarter and Six-Month Period Ended June 30, 2020
-
Siyata Mobile Inc. (SYTA) Prices 2.1M Unit Upsized IPO at $6/Unit
-
Siyata Mobile Announces Pricing of its Upsized US$12.6 Million U.S. Initial Public Offering
-
Siyata Mobile Announces Pricing of its Upsized US$12.6 Million U.S. Initial Public Offering
-
Geovax Labs Inc. (GOVX) Prices 2.56M Unit Common Offering at $5/Unit; Announces Uplisting to NASDAQ and Reverse Share Split
-
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
-
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
-
Titan Pharma (TTNP) Prices 19.44M Share Registered Direct Offering at $0.14/Sh
-
Titan Pharmaceuticals Announces Pricing of $2.7 Million Registered Direct Offering
-
Adamis Pharmaceuticals (ADMP) Prices 16.13M Share Common Offering at $0.62/Sh
-
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Maxim Group Continues to Expand With the Opening of Its Newest Branch Office
-
Lineage Cell Therapeutics to Present at FORCE Wealth Virtual Fireside Chat on September 23, 2020
-
Color Star Technology Co. (HHT) Prices $6.6M Registered Direct Offering
-
Color Star Technology Announces Pricing of $6.6 million Registered Direct Offering
-
Maxim Group Upgrades Cassava Sciences (SAVA) to Buy, AFter Pharma Study Results Released
-
TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020
-
Amplyx to Participate in Upcoming Antifungal Webinar Presented by Maxim Group LLC
-
Industrial Tech Acquisitions, Inc. Announces Closing of $75.0 million Initial Public Offering
-
Industrial Tech Acquisitions, Inc. Announces Closing of $75.0 million Initial Public Offering
-
Castor Maritime Inc. Reports Financial Results for the Three Months and Six Months Ended June 30, 2020
-
Appili Therapeutics to Participate in Upcoming Investor Conferences for H.C. Wainwright & Co. and Maxim Group LLC
-
Matinas BioPharma to Participate on Anti-Fungal CEO Panel During the M-VEST Virtual Conference Series Sponsored by Maxim Group
-
Matinas BioPharma to Participate on Anti-Fungal CEO Panel During the M-VEST Virtual Conference Series Sponsored by Maxim Group
-
PainReform Announces Closing of $20.0 Million Initial Public Offering
-
Industrial Tech Acquisitions Inc. (ITAC) Prices 7.5M Unit IPO at $10/Unit
-
Industrial Tech Acquisitions, Inc. Announces Pricing of $75.0 Million Initial Public Offering
-
Industrial Tech Acquisitions, Inc. Announces Pricing of $75.0 Million Initial Public Offering
-
NetworkNewsBreaks – Data443 Risk Mitigation Inc.’s (ATDS) Trading Surge Highlighted in Micro Cap Daily Article

